Cork senator expresses concern about slow pace of proscribing synthetic drug HHC

Senator Nicole Ryan said there is a major regulatory gap when it comes to vape shop products that contain psychoactive substances such as HHC or other synthetic THC derivatives.
The father of a 12-year-old boy who had to be hospitalised after vaping HHC — a synthetic drug with psychoactive ingredients — said that it took his son several days to recover fully from its effects.
- Introduce a licensing system for all vape shop products containing psychoactive or cannabinoid-derived ingredients. Similar to the system in place for controlled medications, this would restrict sales to licensed premises — potentially limiting them to only regulated outlets;
- Amend the Misuse of Drugs Act to allow for “group-based” or “generic” scheduling of cannabinoid analogues, rather than chasing each new compound individually (as has been the case with substances such as spice, HHC, HHC-O, HHC-P, THC-P, etc). This would future-proof legislation against emerging derivatives;
- Implement mandatory labelling and age restrictions for all vape products, including psychoactive variants — with proper enforcement and penalties for non-compliance;
- Actually start testing these products. This would give valuable statistics on what is in these vapes and also identify the liquids and what they are.